vimarsana.com

Page 9 - ப்ரிஸம் ஆரோக்கியம் வடக்கு டெக்சாஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Alston & Bird Health Care Week in Review - April 2021 #5 | Alston & Bird

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and analyses; and other health policy news. Week in Review Highlight of the Week: This week, CMS released its FY 2022 Hospital Inpatient Prospective Payment System and Long-Term Care Hospital Rates Proposed Rule. Read more about the rule and other news below. I. Regulations, Notices & Guidance On April 26, 2021, the Food and Drug Administration (FDA) issued guidance entitled, Nonclinical Testing of Individualized Antisense Oligonucleotide Drug Products for Severely Debilitating or Life-Threatening Diseases; Draft Guidance for Sponsor-Investigators. FDA is publishing this draft guidance to help sponsor-investigators with developing the nonclinical information that FDA recommends to support an investigational new drug application (IND) for certain individual

BREAKING NEWS: Dallas Pride 2021 tickets on sale now

BREAKING NEWS: Dallas Pride 2021 tickets on sale now Apr 28, 2021 | Marsha Dimes hosts two evenings of entertainment, June 4 and 5, as Dallas celebrates Pride 2021 Tickets are on sale as of 10 a.m. this morning (Wednesday, April 28) for Dallas Pride 2021, two nights of outdoor, in-person variety shows that will “raise awareness and celebrate the LGBTQ+ community,” organizers announced today. Both nights will take place at the Band Shell in Fair Park and will feature an array of talent from North Texas. The shows will also be streamed online at DallasPride.org. “This pandemic has taught us we have to do things a little differently than we would normally do,” said Jaron Turnbow, executive director of Dallas Pride. “And while we are not having a Pride parade nor are we having a festival this year, these shows will allow us to be back out together to celebrate with our friends and allies.”

Healthcare Brief (04/22/21) - D Magazine

Healthcare Brief (04/22/21) Texas Health is No. 7 on Fortune s best places to work list, Medical City Plano earns Level IV maternal designation, and more. By Will Maddox Published in Healthcare Business April 21, 2021 11:00 pm Texas Health Resources is now No. 7 on Fortune’s 100 Best Companies to Work For list after being ranked No. 15 last year. The health system is the top employer in the state and the top ranked health system in the nation. Texas Health has made the list seven years in a row, and is the ranking is decided based on employee feedback surveys. Medical City Plano earned a Level IV Maternal Designation, the highest level of care designated by the Texas Department of State Health Services. This designation means the hospital provides comprehensive care for pregnant and postpartum patients with a wide range of risk and includes medical subspecialists, surgical specialists and behavioral health support.

HIV/AIDS Cases Go Undetected, Untreated During COVID-19 Pandemic : Shots

Brooke Parker, an organizer with the group Solutions Oriented Addiction Response, displays an HIV testing kit in Charleston, W.Va., in March. Outbreaks of HIV/AIDS are expected to rise as resources have been redirected to the fight against COVID-19 delaying and sometimes cutting off HIV testing and treatment. John Raby/AP toggle caption John Raby/AP Brooke Parker, an organizer with the group Solutions Oriented Addiction Response, displays an HIV testing kit in Charleston, W.Va., in March. Outbreaks of HIV/AIDS are expected to rise as resources have been redirected to the fight against COVID-19 delaying and sometimes cutting off HIV testing and treatment.

Strides Against HIV/AIDS In The U S Falter As Resources Diverted To Fight COVID-19

Brooke Parker, an organizer with the group Solutions Oriented Addiction Response, displays an HIV testing kit in Charleston, W.Va., in March. Outbreaks of HIV/AIDS are expected to rise as resources have been redirected to the fight against COVID-19 delaying and sometimes cutting off HIV testing and treatment. (John Raby/AP) Facing a yearlong siege from the coronavirus, the defenses in another, older war are faltering. For the last two decades, HIV/AIDS has been held at bay by potent antiviral drugs, aggressive testing and inventive public education campaigns. But the COVID-19 pandemic has caused profound disruptions in almost every aspect of that battle, grounding outreach teams, sharply curtailing testing and diverting critical staff away from laboratories and medical centers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.